These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1840081)

  • 1. Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats.
    Rowlett JK; Pedigo NW; Bardo MT
    Pharmacol Biochem Behav; 1991 Dec; 40(4):829-34. PubMed ID: 1840081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H; Ekinci AC; Starr MS
    Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebral SCH 23390 and catalepsy in the rat.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1988 Apr; 149(1-2):175-8. PubMed ID: 2899514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood.
    Hietala J; Seppäla T; Lappalainen J; Syvälahti E
    Psychopharmacology (Berl); 1992; 106(4):455-8. PubMed ID: 1349751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].
    Ogren SO; Fuxe K
    Neurosci Lett; 1988 Mar; 85(3):333-8. PubMed ID: 2966309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
    Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
    Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with SCH 23390 increases the production rate of dopamine D1 receptors in the nigro-striatal system of the rat.
    Giorgi O; Pibiri MG; Loi R; Corda MG
    Eur J Pharmacol; 1993 Apr; 245(2):139-45. PubMed ID: 8098282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral hypothalamus-zona incerta region as an output station for the catalepsy induced by the blockade of striatal D1 and D2 dopamine receptors.
    Ossowska K; Wardas J; Golembiowska K; Wolfarth S
    Brain Res; 1990 Jan; 506(2):311-5. PubMed ID: 2154287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
    Banasikowski TJ; Beninger RJ
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist.
    Meller E; Kuga S; Friedhoff AJ; Goldstein M
    Life Sci; 1985 May; 36(19):1857-64. PubMed ID: 3157851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
    Anderson JJ; Randall S; Chase TN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic maturation and SCH 23390-induced catalepsy in the male rat pup.
    Fitzgerald LW; Hannigan JH
    Brain Res Dev Brain Res; 1989 May; 47(1):147-50. PubMed ID: 2525433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
    Parashos SA; Marin C; Chase TN
    Neurosci Lett; 1989 Oct; 105(1-2):169-73. PubMed ID: 2485878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat.
    Caine SB; Heinrichs SC; Coffin VL; Koob GF
    Brain Res; 1995 Sep; 692(1-2):47-56. PubMed ID: 8548319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: interhemispheric effects.
    Yano M; Beverley JA; Steiner H
    Neuroscience; 2006 Jun; 140(2):699-709. PubMed ID: 16549270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.